ACTR-45. A PHASE IB STUDY EVALUATING THE C-MET INHIBITOR INC280 IN COMBINATION WITH BEVACIZUMAB IN GLIOBLASTOMA MULTIFORME (GBM) PATIENTS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details